You have accessJournal of UrologySexual Function/Dysfunction/Andrology: Basic Research II1 Apr 2010874 THE REGULATION OF ANGIOTENSIN II-INDUCED CONTRACTION AND NON ADRENERGIC-NON CHOLINERGIC NEUROTRANSMISSION IN HUMAN CORPUS CAVERNOSAL TISSUE: A ROLE FOR LOSARTAN Hani Ertemi, Faiz Mumtaz, James Bellringer, Philip Thomas, Dimitri Mikhailidis, and Cecil Thompson Hani ErtemiHani Ertemi More articles by this author , Faiz MumtazFaiz Mumtaz More articles by this author , James BellringerJames Bellringer More articles by this author , Philip ThomasPhilip Thomas More articles by this author , Dimitri MikhailidisDimitri Mikhailidis More articles by this author , and Cecil ThompsonCecil Thompson More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.1630AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Angiotensin II (Ang II), a vasoactive peptide, induces smooth muscle contraction and is an important regulator of systemic blood pressure. However, its influence on human corpus cavernosal smooth muscle (CCSM) function has barely been assessed. We have studied the effect Ang II has on human CCSM contractility and the influence of losartan the AT1 receptor antagonist. In addition, the interaction between Ang II and NO in modulating non adrenergic-non cholinergic neurotransmission following electrical field stimulation (EFS) was also assessed with losartan METHODS Experiments were carried out on corpus cavernosal tissue obtained from patients undergoing gender reassignment surgery, using organ baths. CCSM response to Ang II (10-8 – 10-5 M), in the absence and presence of losartan (10-5 M; AT1 receptor antagonist) were determined; together with the effect of losartan on sodium nitroprusside (SNP; NO donor)-mediated CCSM relaxation. In other experiments EFS-induce relaxation were obtained following the addition of cholinergic and cyclooxygenase inhibitors; the effect of losartan on this response was also determined RESULTS The results were expressed as a percentage of the phenylephrine 10-4 M response and showed that Ang II caused a dose dependent contraction of human CCSM strips. The Ang II contractile response was inhibited by losartan (e.g. Ang II; 10-5 M & 10-6 M were reduced by 65% & 78%; p<0.006, respectively). In addition, losartan potentiated the SNP-induced relaxation of CCSM tissue by 9% and 35% at 3x10-7M & 10-7M; p<0.04, respectively. EFS-induced relaxation of CCSM tissue at 8 Hz was also potentiated by losartan (p<0.027) CONCLUSIONS Ang II caused a profound contraction of human CCSM tissue via the activation of AT1 receptor. It is likely that Ang II and NO interact to modulate human cavernosal function, since losartan potentiated SNP- and EFS-mediated CCSM relaxation. These findings further strengthen the argument for the role of Ang II in the regulation of human penile smooth muscle tone, moreover, AT1 receptor inhibition, at least in part, may be a therapeutic approach to treat erectile dysfunction. London, United Kingdom© 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byErtemi H, Mumtaz F, Howie A, Mikhailidis D and Thompson C (2018) Effect of Angiotensin II and its Receptor Antagonists on Human Corpus Cavernous Contractility and Oxidative Stress: Modulation of Nitric Oxide Mediated RelaxationJournal of Urology, VOL. 185, NO. 6, (2414-2420), Online publication date: 1-Jun-2011. Volume 183Issue 4SApril 2010Page: e342 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information Hani Ertemi More articles by this author Faiz Mumtaz More articles by this author James Bellringer More articles by this author Philip Thomas More articles by this author Dimitri Mikhailidis More articles by this author Cecil Thompson More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Read full abstract